Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686588
What this trial is testing

Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent or Metastatic Head and Neck Carcinoma
Biying Chen 20
Testing effectiveness (Phase 2)Looking for participantsNCT07410520
What this trial is testing

PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Secondary Central Nervous System Lymphoma (SCNSL)
The First Affiliated Hospital with Nanjing Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06580574
What this trial is testing

Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers

Who this might be right for
Gastric CancerColon CancerMSI-H+1 more
Peking University 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07432568
What this trial is testing

Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT05484024
What this trial is testing

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms MalignantRadiotherapy
Chinese Academy of Medical Sciences 588
Large-scale testing (Phase 3)Looking for participantsNCT06190782
What this trial is testing

Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic DiseaseRadiotherapy
Fudan University 354
Testing effectiveness (Phase 2)Ended earlyNCT03288545
What this trial is testing

Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Who this might be right for
Carcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more
Astellas Pharma Global Development, Inc. 348
Testing effectiveness (Phase 2)Looking for participantsNCT07559045
What this trial is testing

Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Second Affiliated Hospital of Zunyi Medical University 92
Testing effectiveness (Phase 2)Study completedNCT04055792
What this trial is testing

Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC

Who this might be right for
Extensive Disease Small Cell Lung Cancer
Henan Cancer Hospital 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT07791602
What this trial is testing

Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaLocally Advanced Head and Neck CancerHNSCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 180
Post-approval studies (Phase 4)Active Not RecruitingNCT03849131
What this trial is testing

Patient-Reported AutoImmunity Secondary to Cancer immunothErapy

Who this might be right for
Opportunistic Autoimmune Diseases
University Hospital, Strasbourg, France 905
Large-scale testing (Phase 3)Looking for participantsNCT06958419
What this trial is testing

Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)

Who this might be right for
Immune Checkpoint TherapyRadiotherapyMetastatic Colorectal Cancer (CRC)
Sixth Affiliated Hospital, Sun Yat-sen University 286
Testing effectiveness (Phase 2)UnknownNCT05831969
What this trial is testing

Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC

Who this might be right for
Advanced HCC
Shenyang Tenth People's Hospital 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06793761
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC

Who this might be right for
Head and Neck Cancer
Beijing Tongren Hospital 260
Not applicableStudy completedNCT06031376
What this trial is testing

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

Who this might be right for
Metastatic Colorectal Adenocarcinoma
Hunan Cancer Hospital 106
Not applicableStudy completedNCT04348149
What this trial is testing

Lindera Obtusiloba for Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Jun-Yong Choi 20
Testing effectiveness (Phase 2)UnknownNCT04110093
What this trial is testing

Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerImmunotherapy
Shanghai Changzheng Hospital 120
Not applicableLooking for participantsNCT06512207
What this trial is testing

A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer

Who this might be right for
NSCLC, Stage IIINSCLC, Stage IV
Jinzhou Medical University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710847
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Who this might be right for
Neoplasms, ColorectalSolid TumorColon Cancer+2 more
GlaxoSmithKline 14
Testing effectiveness (Phase 2)Looking for participantsNCT06590259
What this trial is testing

A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM

Who this might be right for
Colorectal Cancer Liver Metastasis
Shanghai 6th People's Hospital 20
Next Page